Shingles vaccine can lower the risk of heart disease, say experts
A recent study from South Korea reveals that the shingles vaccine offers protection beyond preventing the painful rash. Researchers discovered a 23% lower risk of cardiovascular events like stroke and heart failure in vaccinated individuals.
An estimated three to five people out of every 1,000 get shingles each year. Getting a vaccine can reduce the risk. A new study has now revealed that the vaccine can not only prevent you from getting
shingles
, but also reduce the risk of
heart disease
.
A study by researchers from the Kyung Hee University College of Medicine, Seoul, South Kore,a found that people who took a vaccine for shingles have a 23% lower risk of
cardiovascular events
, including stroke, heart failure, and coronary heart disease. The study of more than a million people is published in the
European Heart Journal
.
The study led by Professor Dong Keon Yon found that the protective effect of the vaccine lasts for up to eight years. It is particularly pronounced for men and in those under the age of 60 and with unhealthy lifestyles, such as smoking, drinking alcohol, and being inactive.
'Shingles causes a painful rash and can lead to serious complications, especially in older adults and those with weak immune systems. Previous research shows that, without vaccination, about 30% of people may develop shingles in their lifetime. In addition to the rash, shingles has been linked to a higher risk of heart problems, so we wanted to find out if getting vaccinated could lower this risk,' Prof Yon said in a statement.
The study included 1,271,922 people aged 50 or older. Researchers compiled data from 2012 onward to determine who had received the
shingles vaccine
and matched it with cardiovascular health records and demographic factors, including age, sex, wealth, and lifestyle habits such as smoking, alcohol use, and physical activity. The vaccine used was a
live zoster vaccine
, which contains a weakened form of the varicella zoster virus, that causes shingles.
In many countries, it is now replaced by a non-live, recombinant vaccine.
The study found that in people who got the vaccine, there was a 23% lower risk of cardiovascular events, with a 26% lower risk of major cardiovascular events (a stroke, heart attack or death from heart disease), a 26% lower risk of heart failure and a 22% lower risk of coronary heart disease.
They found that the protective effect was strongest in the two to three years after the shingles vaccine was given, but researchers found that the protection lasted for up to eight years.
'Our study suggests that the shingles vaccine may help lower the risk of heart disease, even in people without known risk factors. This means that vaccination could offer health benefits beyond preventing shingles. There are several reasons why the shingles vaccine may help reduce heart disease. A shingles infection can cause blood vessel damage, inflammation and clot formation that can lead to heart disease. By preventing shingles, vaccination may lower these risks.
Our study found stronger benefits in younger people, probably due to a better immune response, and in men, possibly due to differences in vaccine effectiveness,' Professor Yon said.
Prince Harry's Legal Defeat Sparks Expert Alarm Over Royal Collapse
He also added that this is one of the largest and most comprehensive studies following a healthy general population over up to 12 years. This is also the first time, the researchers have looked at the association between shingles vaccination and 18 different types of cardiovascular disease.
'We were able to account for various other health conditions, lifestyle factors and socioeconomic status, making our findings more robust.
However, as this study is based on an Asian cohort, the results may not apply to all populations. Since the live zoster vaccine is not suitable for everyone, more research on the recombinant vaccine is needed. While we conducted rigorous analysis, this study does not establish a direct causal relationship, so potential bias from other underlying factors should be considered,' he added.
Masterclass for Students. Upskill Young Ones Today!– Join Now
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
25-05-2025
- Time of India
Is extreme bodybuilding putting your heart at risk? Here's what the study says
For a sport that glorifies control, strength, and discipline, bodybuilding conceals a sobering truth—behind the muscle and dedication lies a disproportionately high risk of sudden cardiac death. Bodybuilders push their limits through intense exercise, strict diets, and in some cases, the abuse of performance-enhancing drugs. While the result is a sculpted body, it comes at a cost, and as per a recent study, the tradeoff is human life being cut short. That stark conclusion is drawn from a large-scale study published on May 20 in the European Heart Journal. Researchers tracked 20,286 male bodybuilders who had competed in at least one bodybuilding event between 2005 and 2020. The findings revealed that professional bodybuilders were twice as likely to die from sudden cardiac death as the general population—and five times more likely than amateur bodybuilders. 'Our findings show that the risk of death among male bodybuilders is considerably high. Professional athletes had a markedly higher incidence of sudden cardiac death, suggesting that the level of competition might contribute to this increased risk,' said study co-author Dr. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Zumbido e perda de audição? Médico revela técnica caseira de 1 real para aliviar! Zumbido no ouvido Undo Marco Vecchiato, sports medicine specialist at the University of Padova, Italy. A global Pattern The study identified 121 deaths among competitive bodybuilders, with the average age at death just 45. Of these, about 40% were sudden and heart-related, often caused by underlying, often undetected, cardiac issues. The breakdown of deaths by geography painted a global picture of the crisis: North America: 40.5% (mostly USA) Europe: 38.8% Asia: 7.4% Africa: 6.6% South America: 5% Oceania: 1.7% The data was compiled through official records, social media posts, news reports, forums, and blogs in five different languages. Death reports were meticulously cross-verified and analyzed by two clinicians to confirm the cause of death. The cardiac cost of building muscle Autopsy findings from some of the deceased athletes showed signs of thickened or enlarged hearts and coronary artery disease. In several cases, toxicology reports and public information confirmed the use of anabolic steroids and other performance-enhancing substances, which are known to strain the cardiovascular system. Medical experts warn that these substances, often used without medical oversight, can lead to arrhythmias, heart failure, and sudden cardiac arrest—especially when combined with dehydration and intense training. Psychological toll The study didn't just stop at physical health. Around 15% of the deaths were categorized as sudden traumatic deaths—including suicides, overdoses, car crashes, and murders—highlighting the mental health challenges many athletes face in high-stakes competitive environments. Additional research—including a 2021 Frontiers in Psychology review—points to body dysmorphia, depression, and obsession with appearance as key mental health issues among competitive bodybuilders. 'The pressure to achieve social ideals of muscularity may contribute to psychological distress, body dissatisfaction, and athletes may develop or worsen body dysmorphic disorders,' the study noted. One step to a healthier you—join Times Health+ Yoga and feel the change
Hans India
18-05-2025
- Hans India
Only 3 out of 5 heart failure patients see cardiologist at least once a year: Study
New Delhi: Only around three out of five heart failure patients see a cardiologist at least once a year, according to new research released on Sunday. The study, published in the European Heart Journal, shows that patients who do see a cardiologist once a year are around 24 per cent less likely to die in the following year. It also shows which patients could benefit from seeing a cardiologist once a year and which patients should be seen more often. The research suggests that if cardiologists did see heart failure patients at least once a year, one life could be saved for every 11–16 patients seen. 'In patients with heart failure, the heart is unable to normalise blood flow and pressure. Heart failure can't usually be cured, but with the right treatment, symptoms can often be controlled for many years. At the moment, depending on the patient and their condition, for example whether they have chronic or acute heart failure, they may or may not be seen by a cardiologist,' said Dr Guillaume Baudry from the Clinical Investigation Centre of Nancy University Hospital in France. The study included all French patients living with heart failure in January 2020 who had been diagnosed in the previous five years -- 655,919 people in total. These patients were found using French national medical administrative data. Researchers broke the group down according to whether they had been hospitalised with heart failure in the last year or the last five years, and whether or not they were taking diuretics as a treatment. Diuretics help the body eliminate excess sodium through urine, which reduces the build-up of fluid in the body. Among all groups of patients, researchers found that around two out of every five patients did not see a cardiologist over the course of a year. Those who did see a cardiologist were less likely to die of any cause and less likely to be hospitalised with heart failure in the following year. For patients who had been hospitalised in the last year, four appointments with a cardiologist were optimal. This reduced the risk from 34.3 per cent to 18.2 per cent, according to the study. Dr Baudry said: 'Although there are inherent limitations in observational research, our findings highlight the potential value of specialist follow-up, even in patients who appear clinically stable. Patients should feel encouraged to ask for a cardiology review, particularly if they have recently been in hospital or they are taking diuretics.'
Indian Express
07-05-2025
- Indian Express
Shingles vaccine lowers heart attack risk for 8 years, says new study: Here's what it means for you
People who have been vaccinated against shingles have a 23% lower risk of cardiovascular conditions — with the risk for heart attacks being 22% lower and heart failure 26% lower, according to a large study from South Korea. Importantly, the protective effect of the vaccine lasts for eight years, with the greatest reduction in risks observed between 2 and 3 years after vaccination. The study is based on the insurance data of over 1.2 million people, followed up for six years on average. What is shingles? Shingles is a viral infection that causes painful rashes in stripes across one side of the body. It is caused by the chicken pox virus called varicella-zoster. The disease occurs when the virus gets reactivated years after a bout of chickenpox. A shingles vaccine, recommended for people above 50, can prevent this reactivation by boosting immunity. What did the study find? The study found the risk of overall cardiovascular events was 23% lower in people who had received the vaccine. The risk of a major cardiovascular event was 26% lower, heart failure 26% lower, disorders that affect the blood flow in the brain such as strokes was 24% lower, heart attack was 22% lower, and clotting disorder was 22% lower. 'Our study suggests that the shingles vaccine may help lower the risk of heart disease, even in people without known risk factors. This means that vaccination could offer health benefits beyond preventing shingles,' said study author, Professor Dong Keon Yon from the Kyung Hee University College of Medicine, in a release. Importantly, the study found that the impact was more pronounced in men, those below the age of 60 years, and those with unhealthy lifestyles. How does the vaccine prevent heart attacks? While the mechanism of action is not entirely understood, scientists think it could be because the vaccines prevent shingles, which has been associated with an increased risk of cardiovascular diseases. Previous studies have shown that an infection increased the risk of conditions like heart attack and heart failure by 1.5 to 2 fold. 'A shingles infection can cause blood vessel damage, inflammation and clot formation that can lead to heart disease. By preventing shingles, vaccination may lower these risks. Our study found stronger benefits in younger people, probably due to a better immune response, and in men, possibly due to differences in vaccine effectiveness,' said Prof Yon. Is shingles vaccine available in India? Who should take it? There are two approved shingles vaccines available across the world — one that uses a live, weakened virus and the second that uses a recombinant technology to develop parts of the virus that do not cause disease. Both vaccines are available in India. Shingles vaccines are recommended for individuals over the age of 50 years, especially those living with conditions that weaken the immune system. Will the newer recombinant vaccine also protect the heart? The Korean study is based on data of people who were administered the older live vaccine. Hence, the researchers say, similar studies would have to be conducted in people who have received the newer vaccine.
